Profile data is unavailable for this security.
About the company
4DMedical Limited is an Australia-based medical technology company specializing in advanced diagnostic imaging solutions. Leveraging its proprietary XV Technology and Imbio Technology, the Company provides cutting-edge thoracic imaging that enhances physician diagnoses and management of respiratory conditions. XV technology delivers detailed insights to airflow, lung structure, and regional lung function through a patient’s complete breath cycle. It produces software and hardware products that enable new levels of non-invasive, quantitative analysis of lung function. Its products include CAC (Coronary Artery Calcification), CT-LVAS (Computed Tomography Lung Ventilation Analysis Software), IQ-UIP, LDAf (Functional Lung Density Analysis), LDAi (Lung Density Analysis-Inspiration), LTA (Lung Texture Analysis), PHA Analysis (Pulmonary Hypertension Assessment), XV LVAS (X-ray Velocimetry Lung Ventilation Analysis Software), and XV Scanner.
- Revenue in AUD (TTM)5.85m
- Net income in AUD-30.07m
- Incorporated2012
- Employees--
- Location4DMedical LtdLevel 7/700 Swanston Street, CarltonMELBOURNE 3053AustraliaAUS
- Phone+61 39545-5940
- Websitehttps://4dmedical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shinva Medical Instrument Co Ltd | 1.96bn | 104.12m | 1.89bn | 8.14k | 18.19 | 1.18 | -- | 0.9643 | 0.837 | 0.837 | 15.78 | 12.91 | 0.6286 | 2.20 | 4.50 | 1,177,051.00 | 3.30 | 4.12 | 6.27 | 8.97 | 24.46 | 25.09 | 5.24 | 5.61 | 0.8863 | -- | 0.124 | 21.15 | 0.0874 | 2.71 | 5.75 | -4.29 | 14.30 | 26.58 |
| Sino Medical Sciences Technology Inc | 103.13m | 6.01m | 1.90bn | 691.00 | 315.53 | 10.29 | -- | 18.46 | 0.0706 | 0.0706 | 1.21 | 2.17 | 0.385 | 1.63 | 42.71 | 729,533.10 | 1.69 | -5.65 | 2.05 | -6.45 | 63.92 | 63.65 | 4.40 | -21.72 | 1.71 | 2.66 | 0.2102 | -- | 33.64 | 1.03 | 103.78 | -55.92 | -17.21 | -- |
| HOB Biotech Group Corp Ltd | 79.27m | 7.45m | 1.92bn | 529.00 | 252.83 | 11.16 | -- | 24.18 | 0.5838 | 0.5838 | 6.17 | 13.23 | 0.3938 | 1.50 | 7.30 | 732,482.30 | 3.70 | 7.24 | 4.41 | 8.64 | 57.87 | 64.53 | 9.40 | 16.21 | 1.07 | 14.22 | 0.0805 | 42.82 | 2.01 | 9.20 | -22.24 | -10.43 | 34.88 | -- |
| Xunfei Healthcare Technology Co Ltd | 164.54m | -15.78m | 1.93bn | 928.00 | -- | 10.71 | -- | 11.75 | -0.7218 | -0.7218 | 7.53 | 8.26 | 0.4471 | 3.36 | 1.11 | 998,731.30 | -4.80 | -- | -11.06 | -- | 54.37 | -- | -10.73 | -- | 1.49 | -- | 0.3613 | -- | 31.98 | -- | 8.45 | -- | -- | -- |
| Shanghai Runda Medical Technology Co Ltd | 1.51bn | -32.29m | 1.97bn | 3.14k | -- | 2.30 | -- | 1.30 | -0.2609 | -0.2609 | 12.46 | 6.92 | 0.5237 | 3.68 | 1.46 | 2,360,202.00 | -0.5577 | 3.81 | -1.49 | 10.19 | 21.98 | 26.78 | -1.06 | 5.44 | 0.9723 | 1.16 | 0.5605 | 15.85 | -9.13 | 3.34 | -79.77 | -29.14 | -4.52 | -- |
| Shanghai Haohai Biological Tech Co Ltd | 515.96m | 78.60m | 2.00bn | 2.16k | 27.80 | 1.87 | -- | 3.87 | 1.65 | 1.65 | 10.83 | 24.49 | 0.3512 | 1.53 | 7.84 | 1,169,728.00 | 4.94 | 4.58 | 5.96 | 5.26 | 69.13 | 70.39 | 14.07 | 14.67 | 3.24 | -- | 0.0656 | 42.37 | 1.64 | 10.95 | 1.04 | 2.55 | -1.86 | 14.87 |
| 4DMedical Ltd | 5.85m | -30.07m | 2.01bn | -- | -- | 25.51 | -- | 342.65 | -0.0714 | -0.0714 | 0.0138 | 0.138 | 0.0545 | 0.4858 | 0.8787 | -- | -27.99 | -32.98 | -34.63 | -40.38 | 92.07 | 86.20 | -513.72 | -1,237.52 | 0.8383 | -- | 0.0629 | -- | 55.91 | 36.56 | 16.42 | -- | 3.07 | -- |
| Poly Medicure Ltd. | 278.08m | 54.27m | 2.04bn | 3.08k | 37.79 | -- | 29.32 | 7.33 | 34.11 | 34.11 | 174.83 | -- | -- | -- | -- | 5,780,584.00 | -- | 13.20 | -- | 15.82 | 68.23 | 55.88 | 19.51 | 18.03 | -- | 45.32 | -- | 12.84 | 21.37 | 19.43 | 31.09 | 28.70 | 25.57 | 11.84 |
| Nakanishi Inc | 751.39m | -22.20m | 2.06bn | 2.18k | -- | 1.76 | 65.39 | 2.75 | -29.41 | -29.41 | 969.19 | 1,373.65 | 0.5098 | 1.39 | 8.47 | -- | -1.51 | 8.35 | -1.84 | 9.73 | 56.74 | 59.43 | -2.95 | 16.56 | 2.57 | -- | 0.1901 | 38.60 | 5.37 | 19.69 | -127.96 | -- | 34.84 | 12.47 |
| Qingdao Haier Biomedical Co Ltd | 462.98m | 52.35m | 2.11bn | 2.81k | 40.07 | 2.39 | -- | 4.56 | 0.8144 | 0.8144 | 7.21 | 13.64 | 0.4008 | 4.31 | 5.12 | 806,199.10 | 4.68 | 10.87 | 5.92 | 14.12 | 45.31 | 49.21 | 11.67 | 24.08 | 2.41 | -- | 0.0205 | 28.14 | 0.1288 | 17.67 | -9.71 | 15.03 | -5.53 | 21.16 |
| Holder | Shares | % Held |
|---|---|---|
| Netwealth Investments Ltd.as of 17 Sep 2025 | 2.96m | 0.52% |
| Neuberger Berman Investment Advisers LLCas of 31 Dec 2025 | 2.55m | 0.45% |
| BetaShares Capital Ltd.as of 30 Jan 2026 | 1.40m | 0.25% |
| Antares Capital Partners Ltd.as of 30 Nov 2025 | 392.26k | 0.07% |
| Velten Asset Management GmbHas of 28 Nov 2025 | 120.72k | 0.02% |
| Global X Management (AUS) Ltd.as of 05 Feb 2026 | 3.56k | 0.00% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 600.00 | 0.00% |
